Verastem Oncology a clinical-stage biopharmaceutical company dedicated to the development and commercialization of novel therapies for patients with cancers driven by aberrations in the RAS/MAPK signaling pathway, today announced the issuance of equity-based inducement awards to newly hired employees as…
Thermo Fisher Scientific and NVIDIA Form Strategic Alliance to Transform Laboratories Through AI and Automation Thermo Fisher Scientific a global leader in scientific services and laboratory technologies, has announced a strategic collaboration with NVIDIA aimed at accelerating the adoption of…
Travere Therapeutics Reports Record FILSPARI Performance in 4Q 2025, Advances Regulatory and Clinical Milestones Ahead of 2026 Travere Therapeutics a biopharmaceutical company focused on developing and delivering transformative therapies for people living with rare kidney and metabolic diseases, today announced…
Aptar Expands Its Advanced Eye Care Portfolio with Innovative Delivery Technologies Designed to Improve Precision, Safety, and Patient Experience AptarGroup, a global leader in drug delivery, dispensing, and protection technologies for pharmaceutical, consumer healthcare, and personal care markets, has unveiled…
Partnership Expands Access to Advanced Orthopedic and Musculoskeletal Care Across South Florida Jupiter Medical Center and Hospital for Special Surgery (HSS), the nation’s top-ranked orthopedic hospital, have announced a strategic collaboration aimed at significantly expanding access to world-class musculoskeletal care…
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Fund to Accelerate Life Sciences Innovation The University of Pennsylvania BioNTech SE and Osage University Partners (“OUP”) have announced the launch of a new $50 million venture capital initiative designed to…
BCG and Hippocratic AI Join Forces to Drive Real-World Generative AI Impact Across Biopharma and Medtech Boston Consulting Group (BCG) and Hippocratic AI today announced a global strategic collaboration designed to accelerate the adoption of responsible, real-world generative artificial intelligence…
Appointment Strengthens Company’s Expertise in Translational Medicine and Commercial Strategy Diorasis Therapeutics, a biotechnology company based in Boston and focused on developing durable gene therapies for glaucoma and other ophthalmic disorders, has announced the appointment of Richard A. Kresch, MD,…
Collaboration focuses on improving bedside care delivery through clinical innovation and workflow optimization MUSC Health and Baxter International Inc. a global medtech leader, are entering into a multi-year strategic partnership that aims to enhance the high-quality and safe patient care…
Company advances the second tranche of its EUR 1 billion capital return program Fresenius Medical Care the world’s leading provider of products and services for individuals with renal disease, will accelerate its share buyback program and start the repurchase of…